EURETINA 2024: Tyrosine kinase inhibitors and safety data for patients with non proliferative diabetic retinopathy
Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial
EURETINA 2024: Boris Stanzel, MD, shares research on fluid monitoring and fixation clouds
New research and EURETINA highlights from the director of the "underdog" eye clinic
EURETINA 2024: Kyoko Ohno-Matsui, MD, PhD, shares a keynote on cutting-edge technologies for pathologic myopia
How retinal imaging can provide clinicians a deeper understanding of myopia
EURETINA 2024: Keynote speaker Yousif Subhi, MD, PhD, on keeping patients in focus
Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"
EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)
The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission
EURETINA 2024: Subretinal drusenoid deposit load and correlation with an increased risk of stroke
Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk
EURETINA 2024: Andrea Govetto, MD, PhD, says it takes teamwork to understand macular oedema
We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA
EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment
Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies
EURETINA 2024: Ricardo Leitão Guerra, MD, MSc, FICO, speaks about multimodal imaging
Why having a set process for diagnostic imaging is crucial to patient outcomes
EURETINA 2024: Subretinal gene therapy improves function and structure in patients with Bothnia Dystrophy
Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.
EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination
A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies
EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure
The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients
EURETINA 2024: Efficacy results and patient preference findings from the Pagoda trial
Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences
Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration
Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma
See what our Editorial Advisory Board members are bringing to EURETINA
Spotlight on the retina specialists who make up the Eye Care Network advisory boards
Industry preview: Ophthalmic companies bring updates, new research findings to EURETINA
Businesses in the retina care space tease new technologies and cutting-edge therapeutics
Celebrate World Retina Day at the 2024 EURETINA Congress
As part of the Barcelona meeting, retina specialists can recognise the awareness day early
24th EURETINA Congress: The art of retina on stage in Barcelona
Focus on collaboration, career development and innovation
Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field
Trinity team’s gene therapy offers promising glaucoma and AMD treatment
Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells
ESCRS 2024: Approaching a paradigm shift in cell therapy for corneal oedema and endothelial dysfunction
Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress
iCare debuts slit-lamp-mounted ST500 tonometer
The Finnish company shared technical specifications for the ST500
ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight
Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile
ESCRS 2024: 36-month results following femtosecond laser image-guided high precision trabeculotomy (FLigHT)
Rick Lewis, MD, speaks about a non-pharmaceutical approach to treating glaucoma with laser technology
Magnetic cell therapy for corneal endothelial dysfunction
Phase 1 multicentre study data demonstrate early signs of efficacy
Unite and conquer: Refractive surgery goes on a world tour
The ESCRS Moving Simulator initiative brings surgical training to nations in need
Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS
Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress
BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS
The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family
Corneal nerve regeneration following semaglutide therapy
A case report demonstrates independent effect of GLP-1 receptor agonist
The digital OR: Retina care of tomorrow
The future of the tech-forward surgical suite